Naglaa Zayed

915 citations
65 papers · 697 · h-index 16

Impact in

  • Hepatology top 2%
    • Hepatitis C virus research
    • Liver Disease and Transplantation
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Epidemiology top 10%
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

  • Epidemiology 29
    • Liver Disease Diagnosis and Treatment 24
    • Hepatitis B Virus Studies 10
    • Cytomegalovirus and herpesvirus research 2
  • Hepatology 28
    • Hepatitis C virus research 24
    • Liver Disease and Transplantation 4
Co-authors
Gamal Esmat (16 shared papers)Ayman Yosry (23 shared papers)Noha G. Bader El Din (10 shared papers)Mostafa K. El Awady (9 shared papers)Reem El‐Shenawy (6 shared papers)Ashraf A. Tabll (4 shared papers)Abdel‐Rahman N. Zekri (6 shared papers)Wafaa Elakel (8 shared papers)
Journals
European Journal of Gastroenterology & Hepatology (4 papers)Journal of Medical Virology (3 papers)Abdominal Radiology (2 papers)Journal of Gastroenterology and Hepatology (2 papers)Journal of Advanced Research (2 papers)
Partner nations
EgyptUnited KingdomDenmark

In The Last Decade

Naglaa Zayed

60 papers receiving 681 citations

Peers

Naglaa Zayed
Comparison fields: 5 of 67
  • Hepatology 349
  • Epidemiology 320
  • Cancer Research 104
  • Parasitology 12
  • Molecular Biology 119
Replace Klaus Boeker with:
Klaus Boeker Germany
Samar Samir Youssef Egypt
Ashley Stueck Canada
Ashraf Omar Abdelaziz Egypt
Zhongming Tan China
Gia L. Tyson United States
Efsevia Albanis United States
María Trapero-Marugán Spain
Y‐F Liaw Taiwan
Martin‐Walter Welker Germany
Naglaa Zayed relative to Klaus Boeker Germany Klaus Boeker's profile →
Citations per field
00.5×2×3.0×
Klaus Boeker · 1×
Citations per year

Countries citing papers authored by Naglaa Zayed

Since Specialization
Citations

This map shows the geographic impact of Naglaa Zayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naglaa Zayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naglaa Zayed more than expected).

Fields of papers citing papers by Naglaa Zayed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naglaa Zayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naglaa Zayed. The network helps show where Naglaa Zayed may publish in the future.

Co-authors

The 25 scholars most cited alongside Naglaa Zayed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Naglaa Zayed Line = papers co-authored together Naglaa Zayed links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial
˜The œLancet. Gastroenterology & hepatology ·Imam Waked, Gamal Shiha, Roula Qaqish, Gamal Esmat, Ayman Yosry, Mohamed Hassany, Reham Soliman, Mohammad Mohey, Naglaa Allam, Naglaa Zayed, Tarik Asselah, Coleen Hall, Rebecca Redman, Niloufar Mobashery, Wahid Doss
201654
2
Association of IL28B SNP With Progression of Egyptian HCV Genotype 4 Patients to End Stage Liver Disease
Hepatitis Monthly ·Mostafa K. El Awady, Lotiaf Mostafa, Ashraf A. Tabll, Tawfeek H. Abdelhafez, Noha G. Bader El Din, Naglaa Zayed, Reem El‐Shenawy, Yasmine S. El, Reham M. Hasan, Hosam Zaghlol, (unknown), Ashraf O. Abdel Aziz
201251
3
Circulatory miRNA-484, 524, 615 and 628 expression profiling in HCV mediated HCC among Egyptian patients; implications for diagnosis and staging of hepatic cirrhosis and fibrosis
Journal of Advanced Research ·Shohda A. El‐Maraghy, Ola Adel, Naglaa Zayed, Ayman Yosry, Saeed M. El‐Nahaas, Abdullah Ahmed Gibriel
201938
4
Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy
Journal of Gastroenterology and Hepatology ·Mostafa K. El Awady, Mohamed A. Anany, Gamal Esmat, Naglaa Zayed, Ashraf A. Tabll, Amr Helmy, Abdel Rahman El Zayady, Mohga S. Abdalla, Hayat M. Sharada, (unknown), Wafaa Elakel, Shadia Abdalla, Noha G. Bader El Din
201037
5
Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4
PubMed ·Abdel‐Rahman N. Zekri, Hanaa M. Alam El-Din, Abeer A. Bahnassy, Naglaa Zayed, Waleed Mohamed, samir elmasry, Sayed K Gouda, Gamal Esmat
201036
6
Association of IL28B SNP With Progression of Egyptian HCV Genotype 4 Patients to End Stage Liver Disease
Hepatitis Monthly ·Mostafa K. El Awady, Lotiaf Mostafa, Ashraf A. Tabll, Tawfeek H. Abdelhafez, Noha G. Bader El Din, Naglaa Zayed, Reem El‐Shenawy, Yasmine S. El, Reham M. Hasan, Hosam Zaghlol, (unknown), Ashraf O. Abdel Aziz
201235
7
Non-Invasive Prediction of Hepatic Fibrosis in Patients With Chronic HCV Based on the Routine Pre-Treatment Workup
Hepatitis Monthly ·Marwa Khairy, M.D. HEBA N.A.H. ABDEL MENAEM ABEER A. ABDEL-RAHMAN, Maissa El Raziky, Wafaa Elakel, Naglaa Zayed, Hany Khatab, Gamal Esmat
201234
8
Disease Progression from Chronic Hepatitis C to Cirrhosis and Hepatocellular Carcinoma is Associated with Increasing DNA Promoter Methylation
Asian Pacific Journal of Cancer Prevention ·Abdel‐Rahman N. Zekri, Auhood Nassar, Mahmoud N. El-Rouby, Hend Ibrahim Shousha, Ahmed Barakat, Eman D. El Desouky, Naglaa Zayed, Ola S. Ahmed, Amira Salah El-Din Youssef, Ahmed O. Kaseb, Ashraf Omar Abd El-Aziz, Abeer A. Bahnassy
201334
9
Human cytomegalovirus infection inhibits response of chronic hepatitis‐C‐virus‐infected patients to interferon‐based therapy
Journal of Gastroenterology and Hepatology ·Noha G. Bader El Din, Mai Abd El-Meguid, Ashraf A. Tabll, Mohamed A. Anany, Gamal Esmat, Naglaa Zayed, Amr Helmy, Abdel Rahman El Zayady, Ahmed Barakat, Mostafa K. El Awady
201027
10
Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients
Virus Research ·Noha Mohamed Hosni Shaheen, Naglaa Zayed, Nermine Magdi Riad, Hend Hamed Tamim, Rasha Mohamed Hosny Shahin, Dalia A. Labib, Suzan Elsheikh, Rehab Abdel Moneim, Ayman Yosry, Rania Khalifa
201825
11
MicroRNAs expression profiling in Egyptian colorectal cancer patients
IUBMB Life ·Noha G. Bader El Din, Marwa K. Ibrahim, Reem El‐Shenawy, Ghada M. Salum, Sally Farouk, Naglaa Zayed, Ahmed Khairy, Mostafa K. El Awady
201924
12
Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D
Journal of Medical Virology ·Rabab Fouad, Mahmoud Abdo, Hadeel Gamal Eldeen, Dina Sabry, Mira Atef, Rasha Ahmed, Naglaa Zayed
201522
13
Expression of insulin-like growth factor-II, matrix metalloproteinases, and their tissue inhibitors as predictive markers in the peripheral blood of HCC patients
Biomarkers ·H.M. El Tayebi, W. Salah, Ibrahim H. El Sayed, Abdel‐Rahman N. Zekri, Naglaa Zayed, Salem Salem, Gamal Esmat, Ahmed Ihab Abdelaziz
201121
14
Circulating microRNAs (miR-21, miR-223, miR-885-5p) along the clinical spectrum of HCV-related chronic liver disease in Egyptian patients
Arab Journal of Gastroenterology ·Mona Nasser, Naglaa Zayed, Ahmed Mahmoud Mohamed, Dina Attia, Gamal Esmat, Ahmed Khairy
201917
15
Health-related quality of life in Egyptian patients after liver transplantation
Annals of Hepatology ·Mahasen Mabrouk, Gamal Esmat, Ayman Yosry, Magdy El‐Serafy, Wahid Doss, Naglaa Zayed, Medhat Elsahhar, Sally Awny, Ashraf Omar
201216
16
The assessment of data mining for the prediction of therapeutic outcome in 3719 Egyptian patients with chronic hepatitis C
Clinics and Research in Hepatology and Gastroenterology ·Naglaa Zayed, Abu Bakr Awad, Wafaa Elakel, Wahid Doss, Tahany Awad, Amr Radwan, Mahasen Mabrouk
201215
17
Diagnostic accuracy of acoustic radiation force impulse elastography (ARFI) in comparison to other non-invasive modalities in staging of liver fibrosis in chronic HCV patients: single-center experience
Abdominal Radiology ·Shereen Abdel Alem, Zeinab Abdellatif, Mahasen Mabrouk, Naglaa Zayed, Aisha Elsharkawy, Marwa Khairy, Sherief Musa, Ismail Anwar, Ayman Yosry
201913
18
Tumor necrosis factor-α -G308A polymorphism is associated with liver pathological changes in hepatitis C virus patients
World Journal of Gastroenterology ·Noha G. Bader El Din, Sally Farouk, Reem El‐Shenawy, Marwa K. Ibrahim, Reham M. Dawood, Mostafa M. Elhady, Ahmed Salem, Naglaa Zayed, Ahmed Khairy, Mostafa K. El Awady
201613
19
Increased DNA Damage in Hepatitis C Virus-Related Hepatocellular Carcinoma
DNA and Cell Biology ·S. Shawki, Safa Meshaal, A. Dash, Naglaa Zayed, Mariam Onsy F. Hanna
201412
20
Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian Patients
Journal of Interferon & Cytokine Research ·Noha G. Bader El Din, Ghada M. Salum, Mohamed A. Anany, Marwa K. Ibrahim, Reham M. Dawood, Naglaa Zayed, Yasmine S. El, Reem El‐Shenawy, Mostafa K. El Awady
201510

About Naglaa Zayed

Naglaa Zayed is a scholar working on Epidemiology, Hepatology, Molecular Biology, Cancer Research and Health Information Management, having authored 65 papers that have together received 697 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (24 papers), Hepatitis C virus research (24 papers), Hepatitis B Virus Studies (10 papers), MicroRNA in disease regulation (5 papers), Liver Disease and Transplantation (4 papers), Circular RNAs in diseases (3 papers), Cytomegalovirus and herpesvirus research (2 papers) and Artificial Intelligence in Healthcare (2 papers). The work is most often cited by research in Hepatology (349 citations), Epidemiology (320 citations), Cancer Research (104 citations), Parasitology (12 citations) and Molecular Biology (119 citations). Naglaa Zayed has collaborated with scholars based in Egypt, United Kingdom and Denmark. Frequent co-authors include Gamal Esmat, Ayman Yosry, Noha G. Bader El Din, Mostafa K. El Awady, Reem El‐Shenawy, Ashraf A. Tabll, Abdel‐Rahman N. Zekri, Wafaa Elakel, Abeer A. Bahnassy and Ahmed Khairy. Their work appears in journals such as European Journal of Gastroenterology & Hepatology, Journal of Medical Virology, Abdominal Radiology, Journal of Gastroenterology and Hepatology and Journal of Advanced Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Klaus BoekerBreakdown of academic impact, for papers by Samar Samir YoussefBreakdown of academic impact, for papers by Ashley StueckBreakdown of academic impact, for papers by Ashraf Omar AbdelazizBreakdown of academic impact, for papers by Zhongming TanBreakdown of academic impact, for papers by Gia L. TysonBreakdown of academic impact, for papers by Efsevia AlbanisBreakdown of academic impact, for papers by María Trapero-MarugánBreakdown of academic impact, for papers by Y‐F LiawBreakdown of academic impact, for papers by Martin‐Walter Welker